Conference
A randomized, double-blind, placebo-controlled cross over trial of the effect on quality of life (QOL) of continuing dexamethasone beyond 24 hours following moderately emetogenic chemotherapy in women with breast cancer.
Authors
Vardy JL; Pond GR; Dodd A; Warr D; Seruga B; Clemons MJ; Bordeleau L; Tannock I
Volume
29
Pagination
pp. 9020-9020
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2011
DOI
10.1200/jco.2011.29.15_suppl.9020
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X